$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What should I do if my platelets cannot rise after taking Avatrombopag?
2026-02-01 22:25:32
Check Details
What are the precautions for dabrafenib?
2026-02-01 22:25:32
Check Details
How many months does it take to use a box of dabrafenib
2026-02-01 22:25:32
Check Details
Can I find the new clear domestic reimbursement policy for dabrafenib?
2026-02-01 22:25:32
Check Details
How much does dabrafenib cost per month, and will it bring a great burden to patients?
2026-02-01 22:25:32
Check Details
Is dabrafenib a capsule form?
2026-02-01 22:25:32
Check Details
What disease does the newly launched dabrafenib treat?
2026-02-01 22:25:32
Check Details
Are the side effects of dabrafenib serious?
2026-02-01 22:25:32
Check Details
Is dabrafenib produced by Novartis?
2026-02-01 22:25:32
Check Details
The latest medical insurance reimbursement conditions for dabrafenib have been announced!
2026-02-01 22:25:32
Check Details
Is dabrafenib a new generation of targeted drug? Belong to several generations
2026-02-01 22:25:32
Check Details
Is the new price of dabrafenib high after medical insurance?
2026-02-01 22:25:32
Check Details
1
2
...
387
388
389
390
391
392
393
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Sirolimus (Rapamune) Comprehensive Clinical Guide
5
Lusutrombopag Efficacy, Dosage and Storage Instructions
6
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
7
Cemiplimab (Libtayo) Drug Information
8
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
9
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia
10
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
11
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
12
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis